Page last updated: 2024-11-02

pentoxifylline and Pancytopenia

pentoxifylline has been researched along with Pancytopenia in 2 studies

Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.

Research Excerpts

ExcerptRelevanceReference
"Pentoxifylline was able to ameliorate this nephrotoxic condition as suggested by the change in levels of membrane bound ATPases, MDA and GSH."1.40Carboplatin-induced Fanconi-like syndrome in rats: amelioration by pentoxifylline. ( Bhamre, P; Gandhi, H; Khakhariya, R; Rajput, SJ; Rathod, SP; Trivedi, J; Variya, B, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khakhariya, R1
Rathod, SP1
Gandhi, H1
Variya, B1
Trivedi, J1
Bhamre, P1
Rajput, SJ1
Erikci, AA1
Ozturk, A1
Karagoz, B1
Bilgi, O1
Turken, O1
Top, C1
Kandemir, EG1

Other Studies

2 other studies available for pentoxifylline and Pancytopenia

ArticleYear
Carboplatin-induced Fanconi-like syndrome in rats: amelioration by pentoxifylline.
    Environmental toxicology and pharmacology, 2014, Volume: 37, Issue:1

    Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Carboplatin; Creatin

2014
Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.
    Hematology (Amsterdam, Netherlands), 2008, Volume: 13, Issue:5

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Dexamethason

2008